A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Clinical trial NCT06315322 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06315322
Sponsor: UCB Biopharma SRL
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Childhood Absence Epilepsy Juvenile Absence Epilepsy

Start date: 2024-07-10
Primary completion: 2029-11-16
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.